Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1991 1
1994 2
1995 1
1996 1
1997 7
1998 2
1999 1
2000 2
2001 7
2002 4
2003 3
2004 6
2005 4
2006 7
2007 4
2008 7
2009 9
2010 14
2011 5
2012 11
2013 12
2014 8
2015 7
2016 10
2017 10
2018 13
2019 8
2020 10
2021 9
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

PubMed for id: 389534

177 results

Results by year

Filters applied: . Clear all
Page 1
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.
Graillon T, Romanet P, Camilla C, Gélin C, Appay R, Roche C, Lagarde A, Mougel G, Farah K, Le Bras M, Engelhardt J, Kalamarides M, Peyre M, Amelot A, Emery E, Magro E, Cebula H, Aboukais R, Bauters C, Jouanneau E, Berhouma M, Cuny T, Dufour H, Loiseau H, Figarella-Branger D, Bauchet L, Binquet C, Barlier A, Goudet P. Graillon T, et al. Clin Cancer Res. 2024 Jul 1;30(13):2835-2845. doi: 10.1158/1078-0432.CCR-23-3308. Clin Cancer Res. 2024. PMID: 38630553
A novel BRAF::PTPRN2 fusion in meningioma: a case report.
Sadagopan NS, Nandoliya KR, Youngblood MW, Horbinski CM, Ahrendsen JT, Magill ST. Sadagopan NS, et al. Acta Neuropathol Commun. 2023 Dec 8;11(1):194. doi: 10.1186/s40478-023-01668-w. Acta Neuropathol Commun. 2023. PMID: 38066633 Free PMC article.
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S. Horbinski C, et al. J Natl Compr Canc Netw. 2023 Jan;21(1):12-20. doi: 10.6004/jnccn.2023.0002. J Natl Compr Canc Netw. 2023. PMID: 36634606
Malignant meningioma mTOR mutated and precision medicine.
Villani V, Tanzilli A, Vidiri A, Giangaspero F, Ciliberto G, Olivi A, Pace A. Villani V, et al. Neurol Sci. 2023 Mar;44(3):1073-1075. doi: 10.1007/s10072-022-06575-x. Epub 2022 Dec 26. Neurol Sci. 2023. PMID: 36567410
TRAF7-mutated Fibromyxoid Spindle Cell Tumors Are Associated With an Aggressive Clinical Course and Harbor an Undifferentiated Sarcoma Methylation Signature: A Molecular and Clinicopathologic Study of 3 Cases.
Dermawan JK, Villafania L, Bale T, Singer S, D'Angelo SP, Tap WD, Antonescu CR. Dermawan JK, et al. Am J Surg Pathol. 2023 Feb 1;47(2):270-277. doi: 10.1097/PAS.0000000000001997. Epub 2022 Nov 3. Am J Surg Pathol. 2023. PMID: 36395468 Free PMC article.
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas.
Youngblood MW, Tran AN, Wang W, An S, Scholtens D, Zhang L, O'Shea K, Pokorny JL, Magill ST, Sachdev S, Lukas RV, Ahmed A, Unruh D, Walshon J, McCortney K, Wang Y, Baran A, Sahm F, Aldape K, Chandler JP, David James C, Heimberger AB, Horbinski C. Youngblood MW, et al. Neuro Oncol. 2023 Mar 14;25(3):508-519. doi: 10.1093/neuonc/noac206. Neuro Oncol. 2023. PMID: 35976058 Free PMC article.
177 results